APA (7th ed.) Citation

N, P., SW, P., C, D., D, P., W, Y., S, D., . . . WE, E. (2010). Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemia. Clinical pharmacology and therapeutics, 88(6), 854. https://doi.org/10.1038/clpt.2010.212

Chicago Style (17th ed.) Citation

N, Pottier, et al. "Promoter Polymorphisms in the β-2 Adrenergic Receptor Are Associated with Drug-induced Gene Expression Changes and Response in Acute Lymphoblastic Leukemia." Clinical Pharmacology and Therapeutics 88, no. 6 (2010): 854. https://doi.org/10.1038/clpt.2010.212.

MLA (9th ed.) Citation

N, Pottier, et al. "Promoter Polymorphisms in the β-2 Adrenergic Receptor Are Associated with Drug-induced Gene Expression Changes and Response in Acute Lymphoblastic Leukemia." Clinical Pharmacology and Therapeutics, vol. 88, no. 6, 2010, p. 854, https://doi.org/10.1038/clpt.2010.212.